CD30/TNFRSF8 Antibody (81316) [Unconjugated] Summary
Immunogen |
S. frugiperda insect ovarian cell line Sf 21-derived recombinant human CD30/TNFRSF8 Phe19-Lys379 Accession # P28908 |
Specificity |
Detects human CD30/TNFRSF8 in direct ELISAs and Western blots. In direct ELISAs and Western blots, no cross-reactivity with recombinant human (rh) 4-1BB, rhCD27, recombinant mouse CD30, rhCD40, rhDR3, rhDR6, rhFas, rhGITR, rhHVEM, rhLT beta R, rhNGF R, rhOPG, rhRANK, rhTNF RI, or rhTNF RII is observed. |
Source |
N/A |
Isotype |
IgG1 |
Clonality |
Monoclonal |
Host |
Mouse |
Gene |
TNFRSF8 |
Purity Statement |
Protein A or G purified from hybridoma culture supernatant |
Innovator's Reward |
Test in a species/application not listed above to receive a full credit towards a future purchase. |
Applications/Dilutions
Dilutions |
- ELISA
- Western Blot 1 ug/mL
|
Packaging, Storage & Formulations
Storage |
Use a manual defrost freezer and avoid repeated freeze-thaw cycles. - 12 months from date of receipt, -20 to -70 °C as supplied.
- 1 month, 2 to 8 °C under sterile conditions after reconstitution.
- 6 months, -20 to -70 °C under sterile conditions after reconstitution.
|
Buffer |
Lyophilized from a 0.2 μm filtered solution in PBS with Trehalose. *Small pack size (SP) is supplied either lyophilized or as a 0.2 µm filtered solution in PBS. |
Preservative |
No Preservative |
Reconstitution Instructions |
Reconstitute at 0.5 mg/mL in sterile PBS. |
Notes
This product is produced by and ships from R&D Systems, Inc., a Bio-Techne brand.
Alternate Names for CD30/TNFRSF8 Antibody (81316) [Unconjugated]
Background
CD30,
also known as Ki-1 antigen and TNFRSF8, is a 120 kDa type I
transmembrane glycoprotein belonging to the TNF receptor superfamily (1,
2). Mature human CD30 consists of a 361 amino acid (aa) extracellular
domain (ECD) with six cysteine-rich repeats, a 28 aa transmembrane
segment, and a 188 aa cytoplasmic domain (3). In contrast, mouse and rat
CD30 lack 90 aa of the ECD and contain only three cysteine-rich
repeats. Within common regions of the ECD, human CD30 shares 53% and 49%
aa sequence identity with mouse and rat CD30, respectively. Alternate
splicing of human CD30 generates an isoform that includes only the
C‑terminal 132 aa of the cytoplasmic domain. CD30 is normally expressed
on antigen-stimulated Th cells and B cells (4 - 6). However, it is
upregulated in Hodgkin’s disease (on Reed-Sternberg cells), other
lymphomas, chronic inflammation, and autoimmunity (7). CD30 binds to
CD30 Ligand/TNFSF8 which is expressed on activated Th cells, monocytes,
granulocytes and medullary thymic epithelial cells (1, 5). CD30
signaling costimulates antigen-induced Th0 and Th2 proliferation and
cytokine secretion but favors a Th2-biased immune response (8). In the
absence of antigenic stimulation, it can still induce T cell expression
of IL-13 (9). CD30 contributes to thymic negative selection by inducing
the apoptotic cell death of CD4+CD8+ T cells (10, 11). In B cells, CD30
ligation promotes cellular proliferation and antibody production in
addition to the expression of CXCR4, CCL3, and CCL5 (5, 12). An 85-90
kDa soluble form of CD30 is shed from the cell surface by TACE-mediated
cleavage (13, 14). Soluble CD30 retains the ability to bind CD30 Ligand
and functions as an inhibitor of normal CD30 signaling (15).
- Kennedy, M.K. et al. (2006) Immunology 118:143.
- Tarkowski, M. (2003) Curr. Opin. Hematol. 10:267.
- Durkop, H. et al. (1992) Cell 68:421.
- Hamann, D. et al. (1996) J. Immunol. 156:1387.
- Shanebeck, S.D. et al. (1995) Eur. J. Immunol. 25:2147.
- Gruss, H.-J. et al. (1994) Blood 83:2045.
- Oflzoglu E. et al. (2009) Adv. Exp. Med. Biol. 647:174.
- Del Prete, G. et al. (1995) J. Exp. Med. 182:1655.
- Harlin, H. et al. (2002) J. Immunol. 169:2451.
- Amakawa, R. et al. (1996) Cell 84:551.
- Chiarle, R. et al. (1999) J. Immunol. 163:194.
- Vinante, F. et al. (2002) Blood 99:52.
- Hansen, H.P. et al. (1995) Int. J. Cancer 63:750.
- Hansen, H.P. et al. (2000) J. Immunol. 165:6703.
- Hargreaves, P.G. and A. Al-Shamkhani (2002) Eur. J. Immunol. 32:163.
Limitations
This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are
guaranteed for 1 year from date of receipt.
Customers Who Viewed This Item Also Viewed...
Species: Hu
Applications: BA
Species: Hu, Mu
Applications: Flow-IC, Flow, ICC/IF, IHC, IHC-Fr, IHC-P, IP, WB
Species: Hu
Applications: CyTOF-ready, ELISA, Flow, ICC/IF, IHC, IHC-P, PA, WB
Species: Ca, Hu, Mu, Po
Applications: Flow, ICC/IF, IHC, IHC-Fr, IHC-P, KD
Species: Hu, Rt
Applications: Flow, ICC/IF, IHC, IHC-P, IP, WB
Species: Hu
Applications: BA
Species: Hu, Mu
Applications: Flow, WB
Species: Mu
Applications: CyTOF-ready, Flow, ICC, IHC, WB
Species: Ca, Hu, Mu, Po, Rb, Rt
Applications: Dual ISH-IHC, Flow, ICC/IF, IHC, IHC-Fr, IHC-P, Simple Western, WB
Species: Hu
Applications: BA
Species: Hu
Applications: BA
Species: Hu
Applications: CyTOF-ready, Flow, IHC, WB
Species: Mu, Rt
Applications: Cell Depl, CyTOF-ready, Flow, ICC/IF, IHC, IHC-Fr, IHC-P, IP, InhibTFunc
Species: Hu
Applications: ELISA
Species: Hu, Mu
Applications: ELISA, Flow, ICC/IF, IHC, IHC-Fr, IHC-P
Species: Hu
Applications: ELISA, ICC/IF, S-ELISA, WB
Species: Hu
Applications: IHC, Simple Western, WB
Species: Hu
Applications: BA
Publications for CD30/TNFRSF8 Antibody (MAB2291) (0)
There are no publications for CD30/TNFRSF8 Antibody (MAB2291).
By submitting your publication information earn gift cards and discounts for future purchases.
Reviews for CD30/TNFRSF8 Antibody (MAB2291) (0)
There are no reviews for CD30/TNFRSF8 Antibody (MAB2291).
By submitting a review you will receive an Amazon e-Gift Card or Novus Product Discount.
- Review with no image -- $10/€7/£6/$10 CAD/¥70 Yuan/¥1110 Yen
- Review with an image -- $25/€18/£15/$25 CAD/¥150 Yuan/¥2500 Yen
Product General Protocols
Find general support by application which include: protocols, troubleshooting, illustrated assays, videos and webinars.
Video Protocols
FAQs for CD30/TNFRSF8 Antibody (MAB2291) (0)